Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
498 hedge funds and large institutions have $13.4B invested in Abiomed Inc in 2021 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 173 increasing their positions, 179 reducing their positions, and 25 closing their positions.
120% more first-time investments, than exits
New positions opened: 55 | Existing positions closed: 25
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
5% more funds holding
Funds holding: 474 → 498 (+24)
4% more capital invested
Capital invested by funds: $13B → $13.4B (+$466M)
2% more call options, than puts
Call options by funds: $108M | Put options by funds: $106M
3% less repeat investments, than reductions
Existing positions increased: 173 | Existing positions reduced: 179
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$47.2M |
| 2 |
OCBV
Ownership Capital B.V.
Amsterdam,
Netherlands
|
+$40.7M |
| 3 |
BlackRock
New York
|
+$39.2M |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$34M |
| 5 |
MAMU
Marathon Asset Management (UK)
London,
United Kingdom
|
+$14.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SDJVC
St. Denis J. Villere & Co
New Orleans,
Louisiana
|
-$57.9M |
| 2 |
Renaissance Technologies
New York
|
-$39M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$37.7M |
| 4 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$37.6M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$25.2M |
ABMD Hedge Fund Activity: Q3 2021 in Review
498 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q3 2021, worth a combined $13.4B — up 3.6% from $13B a quarter earlier.
Buyers outnumbered sellers: 55 funds opened new ABMD positions and 25 closed out — a net gain of 30 holders — while 173 added to existing stakes and 179 trimmed.
The largest buyer was AllianceBernstein, adding an estimated $47.2M. The largest seller was St. Denis J. Villere & Co, cutting an estimated $57.9M.
- 498 institutional investors held Abiomed Inc (ABMD) as of Q3 2021, up from 474 in Q2 2021.
- Funds reported $13.4B of Abiomed Inc stock for Q3 2021, up 3.6% quarter-over-quarter.
- 55 funds opened new Abiomed Inc positions in Q3 2021 and 25 closed out, a net change of +30 holders.
- The largest Abiomed Inc buyer in Q3 2021 was AllianceBernstein, an estimated $47.2M added.
- The largest Abiomed Inc seller in Q3 2021 was St. Denis J. Villere & Co, an estimated $57.9M sold.
Based on aggregated 13F filings for Q3 2021.